Back to today’s briefing

Story perspectives

Trump Administration Cuts Endanger FDA and NIH Vital Services

5/17/2025

50 7

Summary

Trump Cuts Health Agencies

The Trump administration's drastic cuts to the FDA and NIH have raised alarms for public health. With over 3,500 FDA positions slashed, vital drug inspections and approvals are at risk. Meanwhile, a staggering $2.4 billion reduction at the NIH jeopardizes crucial research on diverse populations, endangering the future of health innovations in America.

Summary

Kennedy Faces Budget Criticism

Health and Human Services Secretary Robert F. Kennedy Jr. came under fire from both sides of the aisle during congressional hearings. Lawmakers voiced urgent concerns about drastic budget cuts and staffing reductions at HHS, particularly at the NIH, warning that these measures could delay critical treatments for cancer patients and threaten public health during a measles outbreak.

History

Historical Context

The Trump administration's budget cuts to the FDA and NIH echo past tensions between public health funding and political priorities. In the 1980s, similar cuts under President Reagan weakened health agencies, impacting drug safety and research. The 2008 financial crisis further strained health budgets, highlighting the ongoing struggle to balance fiscal responsibility with essential health services, a challenge that persists today.

1 of 3

Trump Cuts Health Agencies

The Trump administration's drastic cuts to the FDA and NIH have raised alarms for public health. With over 3,500 FDA positions slashed, vital drug inspections and approvals are at risk. Meanwhile, a staggering $2.4 billion reduction at the NIH jeopardizes crucial research on diverse populations, endangering the future of health innovations in America.

1 / 3